Mergers: Commission clears acquisition of MTD by QuattroR and IMTC

Daily News 26 / 10 / 2022

Economia - pubblicata il 28 Ottobre 2022

Source: European Commission Spokesperson’s Service

The European Commission has approved, under the EU Merger Regulation, the acquisition of Medical Technology and Devices SA (‘MTD’) of Switzerland, by QuattroR SGR S.p.A. (‘QuattroR’) of Italy and
International Medical Technology Collective S.C.A. (‘IMTC’) of Luxembourg. MTD is a med-tech group that designs, develops and provides globally medical devices, particularly diabetes management
devices, standard and safety sharp devices, electro-medical devices and wound-care products. QuattroR manages a private equity fund. IMTC is an investment company and a subsidiary of
Investindustrial S.A. The Commission concluded that the proposed acquisition would raise no competition concerns, given the absence of overlaps and links between the parties’ business activities.
The transaction was examined under the simplified merger review procedure. More information is available on the Commission’s competition website, in the public

case register
under the case number M.10893.

Corsi e convegni


Economic Report


News Europa